Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
Terason, a portable ultrasound manufacturer based in Massachusetts, is partnering with DiA Imaging Analysis, which is headquartered in Israel, to bring AI to healthcare providers using Terason machines for heart imaging.
Customs and Border Protection will not administer flu vaccines to migrants held in border detention facilities, CBS News reported. The decision comes just weeks before the flu season in the U.S. is expected to hit.
Machine learning is no better than physicians at predicting acute kidney injury (AKI) in the ICU, where it’s a sign of poor outcomes ahead as soon as it appears. However, the AI approach can help mitigate physicians’ tendency to overestimate risks and overtreat low-risk patients.
MyHealthTeams, a San Francisco-based creator of social networks for patients with chronic health conditions, has raised a fresh $9.44 million to expand its existing online spaces and launch new ones.
As speculation continues to swirl around AI’s forthcoming transformation of healthcare, fueling boom times in AI research, a review of the literature has turned up scant evidence the technology is benefiting patients at the consumer level.
VR is quickly becoming a new alternative to more traditional methods of pain management, NPR reported, with patients escaping their chronic pain by strapping on a VR headset and becoming immersed in a different reality.
Machine-learning analyses of satellite images can help identify communities needing healthcare services in some of the most remote parts of the planet, according to a study published Aug. 14 in the Journal of the American Medical Informatics Association.
Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.
The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals.
As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”
